Riyadh to host global biotech leaders for RGMBS 2026

Riyadh will host the Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together scientists, investors, policymakers and health innovators from more than 70 countries. The event is designed to advance Saudi Arabia’s biotech strategy and spotlight research, manufacturing, regulation and investment across the sector.

Why it matters: - The RGMBS 2026 is positioned as a key platform for Saudi Arabia’s biotech ambitions. - The summit is tied to the Kingdom’s National Biotechnology Strategy, which targets $34.6 billion in non-oil GDP from biotechnology by 2040. - The event aims to connect research, investment, regulation and manufacturing across the biotech value chain.

What happened: - The Riyadh Global Medical Biotechnology Summit will take place in Riyadh from Sept. 14-16, 2026. - The fourth edition is expected to bring together more than 15,000 visitors, more than 100 local and international speakers, 200 biotech and health brands, and more than 80 government and industry exhibitors. - Delegations from more than 70 countries are expected. - Organizers are targeting more than 65 agreements and memorandums of understanding over the three-day event. - Registration is open for delegates, exhibitors and industry partners. - Event details, the full scientific program and speaker list are available on the event website.

The details: - The summit’s six themes are artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and skilled workforce development. - The scientific program covers the innovation pathway from population-scale genomics and AI-driven drug discovery to national biomanufacturing, regulatory science, commercialization and investment. - The summit is held under the supervision of the Ministry of National Guard, through its Health Affairs sector. - The event is hosted by King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences. - The Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority are strategic partners. - The summit is designed to show international delegates Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and translational research capacity.

Between the lines: - The summit theme, “Building the Foundations of Biotech Excellence,” signals a shift from global visibility to building deeper sector infrastructure. - Leadership framed durable biotech growth as dependent on advanced labs, integrated research centers, clinical trial networks, biomanufacturing capacity and digital platforms. - The event also highlights international partnerships, including collaborations with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug research. - The emphasis on talent development suggests Saudi Arabia wants to grow local scientific, academic, industrial and regulatory expertise alongside investment.

What’s next: - Organizers will publish the scientific program, speakers and event information ahead of the Sept. 14-16 summit. - The summit will feature scientific sessions, panel discussions, workshops and deal signings. - Saudi Arabia is expected to use the event to advance its biotech strategy and attract more research, investment and industry partnerships.

The bottom line: - RGMBS 2026 is being used as a showcase for Saudi Arabia’s plan to become a regional and global biotech hub, not just a conference for the sector.